Twist Bioscience Corporation (0ME)

Profile

https://www.twistbioscience.com

Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products through a proprietary semiconductor-based platform. This disruptive technology synthesizes DNA on silicon chips rather than traditional plastic plates, enabling high-quality, high-throughput production that is faster and more cost-effective for large-scale applications. The company offers synthetic genes and gene fragments for therapeutics, diagnostics, chemicals and materials, food and agriculture, data storage, and academic research, serving biotech, pharmaceutical, industrial chemical, agricultural firms, and labs. Additional products include oligo pools for targeted next-generation sequencing (NGS), CRISPR gene editing, mutagenesis, DNA origami, DNA computing, and other advanced uses. Twist Bioscience also provides specialized services such as in vivo antibody discovery with humanized transgenic mouse models and customizable oncology DNA comprehensive genomic profiling (CGP) panels that are platform-agnostic for precision medicine. Recent expansions include express delivery for all gene fragments, collaborations for NGS workflows in agrigenomics, and end-to-end solutions with partners. Headquartered in South San Francisco, California, Twist Bioscience operates across the Americas, EMEA, and APAC regions, playing a pivotal role in accelerating biological engineering and innovation in life sciences.